At baseline, the compared groups did not differ with regard to Kf, c (P = 0.3).
When these groups were compared, they did not differ significantly for PFI (p > 0.05) or survival (p > 0.05).
At baseline, compared groups did not differ with regard to K f,c (expressed in g/min/mmHg/100 g) (Table 1).
In cases where all three approaches could be compared results did not differ qualitatively (not shown) and conclusions remain the same.
For the comparison analysis, it was ensured that the scale factors for the compared chips did not differ by a factor larger than 3.
The compared groups did not differ in terms of prevalence of underweight (ADHD 2.3%%, control group 1%%, χ = 1.58, p = 0.21).
When risks for squamous cell and adenocarcinomas of the oesophagus were compared, most did not differ significantly, but statistical power was limited.
If only the datasets from a couple of phenotypes had been used for benchmarking (for example, Figures 6D and 6F), it would have been incorrectly concluded that the six compared methods did not differ in their median accuracy.
The level of RAI expression when comparing lesions did not differ between adenoma and CRC cases, P = 0.909, (Fig 1C).
The levels of ERCC1, OGG1 and RAI expressions when comparing lesions, did not differ between adenomas and CRC cases, P = 0.836, P = 0.341 and P = 0.909, respectively.
